CalciMedica, Inc. Operating Lease Right-of-Use Assets
CalciMedica, Inc. (CALC) had Operating Lease Right-of-Use Assets of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-03-28
- 2023-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2023-09-30: Operating Lease, Right-of-Use Asset $0.00.
- 2023-06-30: Operating Lease, Right-of-Use Asset $0.00.
- 2023-03-31: Operating Lease, Right-of-Use Asset $10.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 |
| 2023-03-31 | $10.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $48.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $290.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $384.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $476.00K 10-Q · filed 2022-05-12 |
| 2022-01-01 | $600.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |